oral etanercept (OPRX-106) - Protalix
Protalix: Q3 FY 2015 Results (Protalix) - Nov 21, 2015 - Anticipated initiation of proof-of-concept study in inflammatory bowel disease in Q1 2016 
Anticipated new trial • Biosimilar
http://phx.corporate-ir.net/phoenix.zhtml?c=101161&p=irol-newsArticle&ID=2110665
 
Nov 21, 2015
 
.